Morris Animal Foundation Announces 2016 Canine Research Grants
DENVER/Dec 13, 2016 – Morris Animal Foundation, committed to solving the critical health problems of animals around the world, announced nine newly funded studies to...
Displaying 71 - 80 of 803 results
Morris Animal Foundation Announces 2017 Feline Research Grants
January 25, 2017 Morris Animal Foundation, committed to solving the critical health problems of animals around the world, announced five newly funded studies to improve...
Morris Animal Foundation Receives $1 Million Grant for Bone Cancer Studies
February 22, 2017 The Petco Foundation and the Blue Buffalo Foundation have partnered to sponsor a $1 million grant for Morris Animal Foundation to help...
Morris Animal Foundation Welcomes New VP of Marketing and Brand Strategy
March 29, 2017 Tiffany Grunert, APR, an award-winning, 20-year marketing professional, has joined Morris Animal Foundation as Vice President of Marketing and Brand Strategy. Grunert...
Morris Animal Foundation Funds Veterinary Student Summer Research Program
June 21, 2017 Since 2005, Morris Animal Foundation has encouraged veterinary students to pursue research careers through its Veterinary Student Scholars program. This year, the...
Morris Animal Foundation Scientific Advisory Board Selects 11 New Research Studies for Wildlife Health with over $775,000 Awarded
DENVER /July 11, 2017 – Morris Animal Foundation announces 11 newly funded studies to advance the health of wildlife species around the world. The studies...
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Assessing the NDY1 Protein as a Potential Treatment for Mast Cell Cancer
The goal of this study is to determine new strategies for treating canine mast cell tumors based on the targeting of a DNA-packaging protein called NDY1.
Developing a Way to Predict Length of Disease-Free Intervals for Dogs with Bone Cancer
This study investigates how cytogenetic changes in canine osteosarcoma affect the duration of disease-free interval when patients are treated with amputation followed by doxorubicin and non-cytotoxic suramin.